Ulisse Biomed S.p.A. (BIT:UBM)
Italy flag Italy · Delayed Price · Currency is EUR
0.7600
+0.0100 (1.33%)
Apr 28, 2025, 11:42 AM CET

Ulisse Biomed Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-5.94--1.31-0.60.22
Upgrade
Depreciation & Amortization
2.92-0.120.250.05
Upgrade
Other Amortization
--0.2--
Upgrade
Loss (Gain) From Sale of Assets
-----0.1
Upgrade
Other Operating Activities
-0.27--0.15-0.14-0.04
Upgrade
Change in Accounts Receivable
0.21-0.10.14-0.37
Upgrade
Change in Inventory
0.19--0.04-0.020.01
Upgrade
Change in Accounts Payable
-0.51-0-0.070.14
Upgrade
Change in Other Net Operating Assets
-0.16-0.110.05-0.51
Upgrade
Operating Cash Flow
-3.56--0.97-0.39-0.6
Upgrade
Capital Expenditures
-0--0.08--0
Upgrade
Sale of Property, Plant & Equipment
----0
Upgrade
Sale (Purchase) of Intangibles
-0.03--0.15-0.96-0.11
Upgrade
Other Investing Activities
0.01---0-0
Upgrade
Investing Cash Flow
-0.03--0.23-0.96-0.11
Upgrade
Short-Term Debt Issued
0.04--0-
Upgrade
Total Debt Issued
0.04--0-
Upgrade
Short-Term Debt Repaid
-----0
Upgrade
Total Debt Repaid
-----0
Upgrade
Net Debt Issued (Repaid)
0.04--0-0
Upgrade
Issuance of Common Stock
2.26-06.3-
Upgrade
Common Dividends Paid
-----0.02
Upgrade
Financing Cash Flow
2.3-06.3-0.02
Upgrade
Net Cash Flow
-1.28--1.24.95-0.73
Upgrade
Free Cash Flow
-3.56--1.05-0.39-0.6
Upgrade
Free Cash Flow Margin
-463.76%--757.58%-140.77%-99.52%
Upgrade
Free Cash Flow Per Share
---0.13-0.05-
Upgrade
Cash Income Tax Paid
---0--
Upgrade
Levered Free Cash Flow
0.01--0.67-1.43-0.64
Upgrade
Unlevered Free Cash Flow
0.01--0.67-1.42-0.64
Upgrade
Change in Net Working Capital
-0.730.6-0.120.340.73
Upgrade
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.